ArticleEuropean urology focus2019

Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator.

Donna P Ankerst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.